← Open Payments lookup

CHADWICK MOREHART: Open Payments

NPI 1912370792 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,380 in 138 payments from 21 companies in 2025. Trend: 2023 $1,917 · 2024 $2,252 · 2025 $2,380

Food & beverage: $2,380
CompanyPaymentsAmount
ABBVIE INC.40$642
Takeda Pharmaceuticals U.S.A., Inc.10$237
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$217
Madrigal Pharmaceuticals11$217
Janssen Biotech, Inc.14$193
Lilly USA, LLC8$173
GENZYME CORPORATION7$164
Phathom Pharmaceuticals, Inc.11$86
Ardelyx, Inc.4$77
Aimmune Therapeutics, Inc.4$64

Products named: RINVOQ, REZDIFFRA, ENTYVIO, TREMFYA, LINZESS, DUPIXENT, OMVOH, RELISTOR.

Industry payments across TX — which companies pay providers there.